DNA Fusion Vaccines: Changing a Fusion Partner
نویسندگان
چکیده
منابع مشابه
Dendritic-Tumor Fusion Cell-Based Cancer Vaccines
Dendritic cells (DCs) are potent antigen-presenting cells (APCs) that play a critical role in the induction of antitumor immunity. Therefore, various strategies have been developed to deliver tumor-associated antigens (TAAs) to DCs as cancer vaccines. The fusion of DCs and whole tumor cells to generate DC-tumor fusion cells (DC-tumor FCs) is an alternative strategy to treat cancer patients. The...
متن کاملAntitumor Response to a Codon-Optimized HPV-16 E7/HSP70 Fusion Antigen DNA Vaccine
Background: Vaccines based on virus-like particles are effective against Human Papilloma Virus (HPV) infection; however, they have not shown a therapeutic effect against HPV-associated diseases. New immunotherapy strategies based on immune responses against tumor antigens can positively affect the clearance of HPV-associated lesions. Objective: To generate two therapeutic fusion DNA vaccines (o...
متن کاملSplenogonadal Fusion Operated as a Malignant Tumor
Splenogonadal fusion is a rare congenital malformation whereby the splenic tissue is found attached or surrounded by the testis, and presents in both continuous and discontinuous forms. Splenogonadal fusion may be misinterpreted as a primary malignant testicular or an adenomatoid tumor. Knowledge about the existence of such an entity is essential in order to preserve the testis during surgical ...
متن کاملمتدهاى Image Fusion
هر سنسورى مأموریت و کاربرد خاصى دارد و اغلب مطلوب ما این است که بطور همزمان در یک تصویر، قدرت تفکیک طیفى و مکانى را با هم داشته باشد چون حجم اطلاعات در یک تصویر بوسیله قدرت تفکیک مکانى و طیفى سیستم تصویربردارى محدود مى گردد و اکثر سیستمهاى تصویربردارى متداول، یکى از این دو ویژگى را عرضه مى دارند، مثل سیستمهاى تصویربردارى tm,spotو... البته در کنار این سیستمها، سیستمهاى دیگرى نیز وجود دارند...
متن کاملHigh Frequency of Fusion Transcripts Involving TCF7L2 in Colorectal Cancer: Novel Fusion Partner and Splice Variants
VTI1A-TCF7L2 was reported as a recurrent fusion gene in colorectal cancer (CRC), found to be expressed in three out of 97 primary cancers, and one cell line, NCI-H508, where a genomic deletion joins the two genes [1]. To investigate this fusion further, we analyzed high-throughput DNA and RNA sequencing data from seven CRC cell lines, and identified the gene RP11-57H14.3 (ENSG00000225292) as a ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Directions in Science
سال: 2002
ISSN: 1538-0033
DOI: 10.1100/tsw.2002.189